Build an investment and financing platform for the medical industry Buy rating
Release time:
2021-08-18
Author:
The domestic medical supply chain finance welcomes golden opportunities, and the layout is at the right time. Supply chain finance refers to the provision of comprehensive financial services to a single enterprise or multiple upstream and downstream enterprises in the industrial supply chain. The domestic medical supply chain finance is facing a golden opportunity
The domestic medical supply chain finance welcomes golden opportunities, and the layout is at the right time. Supply chain finance refers to the provision of comprehensive financial services to a single enterprise or multiple upstream and downstream enterprises in the industrial supply chain. The domestic medical supply chain finance is facing a golden opportunity:
1) Most of the pharmaceutical suppliers are small and medium-sized enterprises, financing is difficult, and medical institutions have a long account receivable cycle and a low rate of bad debts. There is huge room for intervention in supply chain finance;
2) With the deepening of the reform of the pharmaceutical industry, having sufficient cash flow to meet the opportunities and challenges is the key to the survival and development of circulation companies, and the financing needs of the pharmaceutical circulation industry continue to increase. The signing of the "Debt Assignment Agreement" means that the company has fired its first shot in the field of medical supply chain finance.
The scale of the national medical supply chain financial market is 100 billion yuan, and the company's business is extremely imaginative. The company's supply chain financial services are the first to be launched in Sichuan and Chongqing. In 2014, the size of the drug circulation market in Sichuan and Chongqing was about 100 billion yuan (excluding retail terminals). In recent years, the growth rate has remained above 10%. The collection period of accounts receivable and 20% of factoring business needs are conservatively estimated. The scale of accounts receivable for medical supply chain finance in Sichuan and Chongqing is at least 20 billion yuan, and it is expanding with the expansion of the pharmaceutical circulation market. In the same way, it is estimated that the scale of accounts receivable for the medical supply chain nationwide is about 250 billion yuan. Since the company can accelerate capital turnover and achieve rapid scale expansion through asset securitization, the medical supply chain financial business is expected to be based in Sichuan and Chongqing and spread across the country. It is estimated that the company's investment in supply chain finance in 2015 will be about 5 billion yuan.
Previous page
Next page
Online Message
Latest News
Hospital Bed Manufacturer Guide: How to Choose a Reliable Supplier in 2026
Looking for a trusted hospital bed manufacturer in India? This 2026 guide covers bed types, INR price benchmarks, BIS/CE/ISO certifications, government scheme eligibility, and after-sales service networks to help procurement managers make the right choice.
05
2026
/
08
Automatic hospital bed price guide: key factors & buying tips (2026)
Comprehensive 2026 guide to automatic hospital bed prices in India. Compare electric, ICU, fowler, and home care bed costs, top brands, GST impact, EMI options, and buying tips for hospitals and families.
05
2026
/
08
Hospital folding bed buying guide: key features, types & practical tips
Complete 2026 buying guide for hospital folding beds in India. Compare types, features, prices (₹2,500–₹1,20,000), safety standards and top procurement tips for hospitals, nursing homes and home care.
05
2026
/
08
Patient bed cost guide: What to expect and how to save in 2026
Complete 2026 guide to patient bed cost in India. Compare prices from ₹8,000 to ₹5,00,000+, explore ICU bed rental charges, home nursing bed options, brand comparisons, GST impact, and BIS certification requirements for hospitals and home buyers.
03
2026
/
08